Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 67-72

  Pachmerhiwala, Rashida ^a   Bhide, Nirmal ^a   Straiko, Megan ^a   Gudelsky, Gary A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Glucose; Glycogen; Hyperthermia; MDMA; Microdialysis

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; FLUOXETINE; GLUCOSE; NORADRENALIN; PRAZOSIN; PROPRANOLOL; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; BRAIN REGION; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR SPACE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLYCOGEN ANALYSIS; GLYCOGENOLYSIS; HYPERTHERMIA; HYPOTHERMIA; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; BRAIN; FEVER; FLUOXETINE; GLUCOSE; GLYCOGENOLYSIS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOREPINEPHRINE; PRAZOSIN; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; SEROTONIN;

EID: 77955773353     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.07.004     Document Type: Article

References (34)

1. Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A., DiChiara G. Intravenous administration of ecstasy (3,4-methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur. J. Pharmacol. 2001, 418:207-2011.
2. Banks M.L., Buzare S.K., Gehret C.M., Monroy A.N., Kenaston M.A., Mills E.M., Sprague J.E. Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis. Eur. J. Pharmacol. 2009, 615:257-261.
3. Colado M.I., Murray T.K., Green A.R. 5-HT lossin rat brain following 3, 4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizolcilpine. Br. J. Pharmacol. 1993, 108:583-589.
4. 2 receptors induces glycogenolysis in the rat brain. Eur. J. Pharmacol. 2003, 464:135-140.
5. Darvesh A.S., Gudelsky G.A. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Neurotoxicol. Tetral. 2004, 26:571-577.
6. Darvesh A.S., Shankaran M., Gudelsky G.A. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J. Pharmacol. Exp. Ther. 2002, 300:138-144.
7. Dringen R., Gebhardt R., Hamprecht B. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res. 1993, 623:208-214.
8. Fischer Y., Thomas J., Kamp J., Jungling E., Rose H., Carpene, Kammermeier H. 5-Hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction. Biochem. J. 1995, 311(Pt 2):575-583.
9. Fischer H.S., Zernig G., Schatz D.S., Humpel C., Saria A. MDMA (ecstasy) enhances basal acetylcholine release in brain slices of the rat striatum. Eur. J. Neurosci. 2000, 12:1385-1390.
10. Fray A.E., Forsyth R.J., Boutelle M.G., Fillenz M. The mechanism controlling physiologically stimulated changes in rat brain glucose and lactate: a micodialysis study. J. Physiol. 1996, 496:49-57.
11. Gramsbergen J.B., Cumming P. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA. "Ecstasy") administration in awake rats. Neurochem. Int. 2007, 51:8-15.
12. Gudelsky G.A., Yamamoto B.K. Actions of 3, 4-methylenedioxy-methamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 2008, 90:198-207.
13. Hajduch E., Rencurel F., Balendran A., Batty I.H., Downes C.P., Hundal H.S. Serotonin (5-hydroxytryptamine), an novel regulator of glucose transport in rat skeletal muscle. J. Biol. Chem. 1999, 274:13563-13568.
14. 2A receptor in the hyperlocomotive and hyperthermic effects of 3,4-methylenedioxymethamphetamine. Psychopharmacology 2005, 178:505-513.
15. Huether G., Zhou D., Ruther E. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") and its congeners. J. Neural Transm. 1997, 104:771-794.
16. Liechti M.E., Baumann C., Gamma A., Vollenweider F.X. Acute psychological effects of 3, 4-methylenedioxymethamphetamine (MDMA) are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 2000, 22:513-522.
17. Moore M.C., DiCostnazo C.A., Dardevet D., Lautz M., Farmer B., Cherrington A.D. Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E556-E663.
18. Nahorski S.R., Rogers K.J. An enzymatic fluorimetric micro method for determination of glycogen. Anal. Biochem. 1972, 49:492-497.
19. Nahorski S.R., Rogers K.J. The role of catecholamines in the action of amphetamine and L-DOPA on cerebral energy metabolism. Neuropharmacology 1975, 14:283-290.
20. Nahorski S.R., Rogers K.J., Edwards C. Cerebral glycogenolysis and stimulation of beta-adrenoreceptors and histamine H2 receptors. Brain Res. 1975, 92:529-533.
21. Nair S.G., Gudelsky G.A. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology 2006, 184:182-189.
22. Nash J.F., Meltzer H.Y., Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after administration of 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 1988, 245:873-879.
23. 2C receptors. Neurosci. Lett. 1994, 177:111-115.
24. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press.
25. 2A receptor. Brain Res. 1995, 680:9-15.
26. Quate L., McBean D.E., Ritchie I.M., Olverman H.J., Kelly P.A.T. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilization in the dark agouti rat. Psychopharmacology 2004, 173:287-295.
27. Schimdt C.J., Black C.K., Abbate G.M., Taylor V.L. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5HT2 receptors. Brain Res. 1990, 529:85-90.
28. Shankaran M., Yamamoto B.K., Gudelsky G.A. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3, 4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 1999, 385:103-110.
29. Soto-Montenegro M.L., Vaquero J.J., Arango C., Ricaurte G., Garcia-Bareno P., Desco M. Effects of MDMA on blood glucose levels and brain glucose metabolism. Eur. J. Nucl. Mol. Imaging 2007, 34:916-925.
30. Spanos L.J., Yamamoto B.K. Acute and subchronic effects of methylenedioxy-methamphetamine (MDMA) on locomotion and serotonin syndrome behavior in the rat. Pharmacol. Biochem. Behav. 1989, 32:835-840.
31. Sprague J.E., Banks M.L., Cook V.J., Mills E.M. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3, 4-methylenedioxymethamphetamine (Ecstasy). J. Pharmacol. Exp. Ther. 2003, 305:159-166.
32. Sprauge J.E., Moze P., Caden D., Rusyniak D.E., Holmes C., Goldstein D.S., Mills E.M. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) in an animal model. Crit. Care Med. 2005, 33:1311-1316.
33. Wilkerson G., London E.D. Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Neuropharmacology 1989, 28:1129-1138.
34. Yamamoto B., Pehek E. A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res. 1990, 506:236-242.